Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diamandis

Showing results (551-560 of 924) with videos related to

Pageof 93
Sort By:
Clinical Biochemistry|December 23, 2009
Direct measurement of serum free testosterone by ultrafiltration followed by liquid chromatography tandem mass spectrometryYu Chen, Mehrdad Yazdanpanah, Xiao Yan Wang, et al.
Molecular Cancer Research : MCR|October 2, 2012
Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissueGeorge S Karagiannis, Theofilos Poutahidis, Susan E Erdman, et al.
Molecular & Cellular Proteomics : MCP|March 28, 2015
Immunocapture-Selected Reaction Monitoring Screening Facilitates the Development of ELISA for the Measurement of Native TEX101 in Biological FluidsDimitrios Korbakis, Davor Brinc, Christina Schiza, et al.
Oncotarget|March 13, 2012
Proteomic signatures of the desmoplastic invasion front reveal collagen type XII as a marker of myofibroblastic differentiation during colorectal cancer metastasisGeorge S Karagiannis, Constantina Petraki, Ioannis Prassas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2004
Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic markerAndreas Scorilas, Carla A Borgoño, Nadia Harbeck, et al.
Molecular Cancer Therapeutics|August 1, 2019
Serum PD-1 Is Elevated after Pembrolizumab Treatment but Has No Predictive ValueMilena Music, Marco A J Iafolla, Annie He Ren, et al.
Clinical Chemistry and Laboratory Medicine|December 18, 2012
Glycoproteomic identification of potential glycoprotein biomarkers in ovarian cancer proximal fluidsUros Kuzmanov, Natasha Musrap, Hari Kosanam, et al.
Clinical Biochemistry|November 4, 2009
Nidogen-2: a new serum biomarker for ovarian cancerCynthia Kuk, C Geeth Gunawardana, Antoninus Soosaipillai, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 16, 2004
Short tandem repeat polymorphism and cancer risk: influence of laboratory analysis on epidemiologic findingsNguyet Tran, Bupinder S Bharaj, Eleftherios P Diamandis, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 25, 2003
Are cardiovascular and sympathoadrenal effects of human "new pressor protein" preparations attributable to human coagulation beta-FXIIa?Peter C Papageorgiou, Ali Pourdjabbar, Akis A Amfilochiadis, et al.
Pageof 93

Showing results (551-560 of 924) with videos related to

Sort By:
Pageof 93
Clinical Biochemistry|December 23, 2009
Direct measurement of serum free testosterone by ultrafiltration followed by liquid chromatography tandem mass spectrometryYu Chen, Mehrdad Yazdanpanah, Xiao Yan Wang, et al.
Molecular Cancer Research : MCR|October 2, 2012
Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissueGeorge S Karagiannis, Theofilos Poutahidis, Susan E Erdman, et al.
Molecular & Cellular Proteomics : MCP|March 28, 2015
Immunocapture-Selected Reaction Monitoring Screening Facilitates the Development of ELISA for the Measurement of Native TEX101 in Biological FluidsDimitrios Korbakis, Davor Brinc, Christina Schiza, et al.
Oncotarget|March 13, 2012
Proteomic signatures of the desmoplastic invasion front reveal collagen type XII as a marker of myofibroblastic differentiation during colorectal cancer metastasisGeorge S Karagiannis, Constantina Petraki, Ioannis Prassas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2004
Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic markerAndreas Scorilas, Carla A Borgoño, Nadia Harbeck, et al.
Molecular Cancer Therapeutics|August 1, 2019
Serum PD-1 Is Elevated after Pembrolizumab Treatment but Has No Predictive ValueMilena Music, Marco A J Iafolla, Annie He Ren, et al.
Clinical Chemistry and Laboratory Medicine|December 18, 2012
Glycoproteomic identification of potential glycoprotein biomarkers in ovarian cancer proximal fluidsUros Kuzmanov, Natasha Musrap, Hari Kosanam, et al.
Clinical Biochemistry|November 4, 2009
Nidogen-2: a new serum biomarker for ovarian cancerCynthia Kuk, C Geeth Gunawardana, Antoninus Soosaipillai, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 16, 2004
Short tandem repeat polymorphism and cancer risk: influence of laboratory analysis on epidemiologic findingsNguyet Tran, Bupinder S Bharaj, Eleftherios P Diamandis, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 25, 2003
Are cardiovascular and sympathoadrenal effects of human "new pressor protein" preparations attributable to human coagulation beta-FXIIa?Peter C Papageorgiou, Ali Pourdjabbar, Akis A Amfilochiadis, et al.
Pageof 93